CANDEL THERAPEUTICS, INC. (CADL) Net Margin
- 2022-12-31: Net Margin -16396.77%.
- 2022-09-30: Net Margin -28025.81%.
- 2022-06-30: Net Margin -13383.87%.
- 2022-03-31: Net Margin -2819.35%.
Complete source-backed net margin history.
- Available history
- 2020-06-30 to 2022-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2022-12-31 | -16396.77% |
| 2022-09-30 | -28025.81% |
| 2022-06-30 | -13383.87% |
| 2022-03-31 | -2819.35% |
| 2021-12-31 | 5148.39% |
| 2021-09-30 | -52135.48% |
| 2021-06-30 | -55096.77% |
| 2021-03-31 | -14445.16% |
| 2020-12-31 | -33800.00% |
| 2020-09-30 | -8238.71% |
| 2020-06-30 | -9277.42% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2022-12-31 | -15035.20% |
| 2021-12-31 | -28899.20% |
| 2020-12-31 | -14144.00% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |